In the quarter, growth in cancer drugs moderated generic competition and pricing pressures in respiratory and diabetes markets. We expect this trend to continue, but the gains in cancer drugs should ...
BOSTON, April 9, 2013 /PRNewswire/ -- Bio-IT World -- Accelrys, Inc. (NASDAQ: ACCL), a leading provider of scientific innovation lifecycle management software, has announced the launch of the Accelrys ...
SAN DIEGO, Feb. 6, 2014 /PRNewswire/ -- Accelrys, Inc. (NASDAQ: ACCL), a leading provider of scientific innovation lifecycle management software, has announced the launch of ScienceCloud, a new ...
Prellis Biologics, Inc. today announced that it has generated 300 human IgG antibodies that bind to either the S1 or S2 spike protein of the SARS-CoV2-Wuhan strain of the novel coronavirus. Using the ...
One of the biggest challenges of evaluating and planning the energy economy is the existence of what economists call externalities, or externalized costs. Any activity that causes damage to the ...
Accelrys, Inc., a leading provider of scientific innovation lifecycle management software, has announced the launch of ScienceCloud, a new SaaS-based information management and collaboration workspace ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results